Bracco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRACCO, and what generic alternatives to BRACCO drugs are available?
BRACCO has forty approved drugs.
There are three US patents protecting BRACCO drugs.
There are thirty-seven patent family members on BRACCO drugs in twelve countries and seventy-four supplementary protection certificates in eight countries.
Summary for Bracco
| International Patents: | 37 |
| US Patents: | 3 |
| Tradenames: | 64 |
| Ingredients: | 32 |
| NDAs: | 40 |
Drugs and US Patents for Bracco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bracco | RENOCAL-76 | diatrizoate meglumine; diatrizoate sodium | INJECTABLE;INJECTION | 089347-001 | Jun 1, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bracco | ISOVUE-200 | iopamidol | INJECTABLE;INJECTION | 020327-001 | Oct 12, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bracco | ORAGRAFIN SODIUM | ipodate sodium | CAPSULE;ORAL | 012967-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bracco | MULTIHANCE MULTIPACK | gadobenate dimeglumine | INJECTABLE;INTRAVENOUS | 021358-002 | Nov 23, 2004 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Bracco | ISOVUE-370 | iopamidol | INJECTABLE;INJECTION | 018735-003 | Dec 31, 1985 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Bracco | ISOVUE-250 | iopamidol | INJECTABLE;INJECTION | 018735-007 | Jul 6, 1992 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Bracco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | 5,474,756 | ⤷ Try a Trial |
| Bracco | MULTIHANCE MULTIPACK | gadobenate dimeglumine | INJECTABLE;INTRAVENOUS | 021358-001 | Nov 23, 2004 | 4,916,246 | ⤷ Try a Trial |
| Bracco | CARDIOGEN-82 | rubidium chloride rb-82 | INJECTABLE;INJECTION | 019414-001 | Dec 29, 1989 | 4,562,829 | ⤷ Try a Trial |
| Bracco | MULTIHANCE | gadobenate dimeglumine | INJECTABLE;INTRAVENOUS | 021357-001 | Nov 23, 2004 | 4,916,246 | ⤷ Try a Trial |
| Bracco | PROHANCE | gadoteridol | INJECTABLE;INJECTION | 020131-001 | Nov 16, 1992 | 5,846,519 | ⤷ Try a Trial |
| Bracco | ISOVUE-M 300 | iopamidol | INJECTABLE;INJECTION | 018735-004 | Dec 31, 1985 | 4,001,323 | ⤷ Try a Trial |
| Bracco | LUMASON | sulfur hexafluoride lipid-type a microspheres | FOR SUSPENSION;INTRAVENOUS | 203684-001 | Oct 15, 2014 | 5,686,060 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Bracco Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 102626600 | ⤷ Try a Trial |
| Canada | 3137088 | ⤷ Try a Trial |
| Japan | 7148742 | ⤷ Try a Trial |
| Canada | 3098380 | ⤷ Try a Trial |
| European Patent Office | 3969064 | ⤷ Try a Trial |
| Japan | 2021529730 | ⤷ Try a Trial |
| Israel | 288095 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Bracco Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2822954 | 18C1035 | France | ⤷ Try a Trial | PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625 |
| 1912999 | 2014/058 | Ireland | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR, OR A SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REGISTRATION NO/DATE: EU/1/14/924/001-002 20140516 |
| 2822954 | LUC00083 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: BICTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR BICTEGRAVIR SODIUM; AUTHORISATION NUMBER AND DATE: EU/1/18/1289 20180625 |
| 1713823 | 1490064-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516 |
| 3141251 | 301099 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: A MEDICINAL PRODUCT CONSISTING OF A COMBINATION OF A FIRST DOSE PHARMACEUTICAL COMPOSITION AND A SECOND DOSE PHARMACEUTICAL COMPOSITION, THE FIRST DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS POLYETHYLENE GLYCOL, SODIUM SULPHATE, SODIUM CHLORIDE AND POTASSIUM CHLORIDE AND THE SECOND DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS POLYETHYLENE GLYCOL, ASCORBIC ACID, SODIUM ASCORBATE, SODIUM CHLORIDE AND POTASSIUM CHLORIDE; NATIONAL REGISTRATION NO/DATE: RVG 120195 20171114; FIRST REGISTRATION: IS IS/1/17/083/01 20171016 |
| 1556389 | 2015/074 | Ireland | ⤷ Try a Trial | PRODUCT NAME: CEFTOLOZANE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR A SULFURIC ACID SALT; REGISTRATION NO/DATE: EU/1/15/1032/001 20150918 |
| 1556389 | 16C0004 | France | ⤷ Try a Trial | PRODUCT NAME: CEFTOLOZANE,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,PLUS PARTICULIEREMENT UN SEL D'ACIDE SULFURIQUE; REGISTRATION NO/DATE: EU/1/15/1032 20150922 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
